NZ589360A - Radiohalogen 18F substituted on a pyridine arboxamide compound - Google Patents
Radiohalogen 18F substituted on a pyridine arboxamide compoundInfo
- Publication number
- NZ589360A NZ589360A NZ589360A NZ58936009A NZ589360A NZ 589360 A NZ589360 A NZ 589360A NZ 589360 A NZ589360 A NZ 589360A NZ 58936009 A NZ58936009 A NZ 58936009A NZ 589360 A NZ589360 A NZ 589360A
- Authority
- NZ
- New Zealand
- Prior art keywords
- compound
- substituted
- leaving group
- precursor
- ring
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/81—Amides; Imides
- C07D213/82—Amides; Imides in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0455—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
A compound comprising a pyridine carboxamide structure wherein an aromatic ring in the structure is substituted radio halogen atom 18F (fluorine) and wherein the substitution on the amide nitrogen atom is: a hydrogen atom and a tertiary aminoalkyl group; or such that the amide nitrogen is a member of a saturated ring structure having a second nitrogen atom in the ring; or a pharmaceutically acceptable salt of said compound. A structural representation of a possible compound is shown in formula (I). R3 and R4 can form an aryl ring fused to the pyridine ring. Also disclosed is a process for making a compound comprising the step of treating a precursor comprising a leaving group so as to replace said leaving group with the radiohalogen atom18F, said precursor comprising a pyridine carboxamide structure wherein an aromatic ring in the structure is substituted with said leaving group and wherein the substitution on the amide nitrogen atom is a hydrogen atom and a tertiary aminoalkyl group; or the process includes the step of treating a solution of a precursor comprising a chloro leaving group in dimethylformamide with K[18F]-K2.2.2 K2CO3, and heating the mixture at 150 degrees C for 10 minutes; said precursor comprising a pyridine carboxamide structure wherein an aromatic ring in the structure is substituted with said leaving group and wherein the substitution on the amide nitrogen atom is a hydrogen atom and a tertiary aminoalkyl group, such that the compound binds to melanin.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2008901989A AU2008901989A0 (en) | 2008-04-22 | Nicotinamide derivatives | |
PCT/AU2009/000504 WO2009129573A1 (en) | 2008-04-22 | 2009-04-22 | Nicotinamide derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ589360A true NZ589360A (en) | 2012-08-31 |
Family
ID=41216339
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ589360A NZ589360A (en) | 2008-04-22 | 2009-04-22 | Radiohalogen 18F substituted on a pyridine arboxamide compound |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP2285778A4 (en) |
CN (1) | CN102232067A (en) |
AU (1) | AU2009240785A1 (en) |
CA (1) | CA2753532A1 (en) |
NZ (1) | NZ589360A (en) |
WO (1) | WO2009129573A1 (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20120107240A1 (en) * | 2010-11-03 | 2012-05-03 | The Board Of Trustees Of The Leland Stanford Junior University | Probes and methods of melanoma imaging |
US20150023877A1 (en) * | 2013-07-18 | 2015-01-22 | The Board Of Trustees Of The Leland Stanford Junior University | Methods of parkinsons disease diagnosis and monitoring treatment |
JP2015193545A (en) * | 2014-03-31 | 2015-11-05 | 国立大学法人京都大学 | 2-(3-pyridinyl)-1h-benzimidazole derivative compound, and radioactive pharmaceuticals containing the same |
CN107556236B (en) * | 2017-08-25 | 2020-01-21 | 华中科技大学同济医学院附属协和医院 | Isotope-substituted targeted melanoma positron imaging agent and preparation method and application thereof |
WO2020004785A1 (en) * | 2018-06-28 | 2020-01-02 | 전남대학교 산학협력단 | Radioactive compound for treatment of melanoma and use thereof |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2904317A1 (en) * | 2006-07-27 | 2008-02-01 | Inst Nat Sante Rech Med | ANALOGUES OF HALOGENOBENZAMIDES BRANDED AS RADIOPHARMACEUTICALS |
EP2085390A1 (en) * | 2008-01-31 | 2009-08-05 | Institut National De La Sante Et De La Recherche Medicale (Inserm) | Labelled analogues of halobenzamides as multimodal radiopharmaceuticals and their precursors |
-
2009
- 2009-04-22 CN CN2009801237149A patent/CN102232067A/en active Pending
- 2009-04-22 EP EP09733745A patent/EP2285778A4/en not_active Withdrawn
- 2009-04-22 WO PCT/AU2009/000504 patent/WO2009129573A1/en active Application Filing
- 2009-04-22 CA CA2753532A patent/CA2753532A1/en not_active Abandoned
- 2009-04-22 NZ NZ589360A patent/NZ589360A/en not_active IP Right Cessation
- 2009-04-22 AU AU2009240785A patent/AU2009240785A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2285778A4 (en) | 2011-05-11 |
AU2009240785A1 (en) | 2009-10-29 |
CA2753532A1 (en) | 2009-10-29 |
EP2285778A1 (en) | 2011-02-23 |
CN102232067A (en) | 2011-11-02 |
WO2009129573A1 (en) | 2009-10-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UA99257C2 (en) | Process for making 3-substituted 2-amino-5-halobenzamides | |
MXPA06000716A (en) | Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors. | |
SI1881967T1 (en) | Substituted benzo(d)isoxazol-3-yl amine compounds as analgesics | |
NZ589360A (en) | Radiohalogen 18F substituted on a pyridine arboxamide compound | |
NZ593168A (en) | Stable insecticide compositions and methods for producing same | |
TW200718692A (en) | Dihydrobenzofuran derivatives and uses thereof | |
TW200626601A (en) | Novel compounds | |
MX2013007148A (en) | 2-arylimidazo[1,2-b]pyridazine, 2-phenylimidazo[1,2-a]pyridine, and 2-phenylimidazo[1,2-a]pyrazine derivatives. | |
EA023824B1 (en) | 3,4-DIHYDROPYRROLO[1,2-a]PYRAZIN-1-YLAMINE DERIVATIVES USEFUL AS INHIBITORS OF BETA-SECRETASE (BACE) | |
NZ586082A (en) | Indole compounds and methods for treating visceral pain | |
NZ592827A (en) | Methods of preparing quinoline derivatives | |
MX2010007714A (en) | Fused pyridines active as inhibitors of c-met. | |
TW200716648A (en) | Heterocycles as nicotinic acid receptor agonists for the treatment of dyslipidemia | |
WO2010117323A8 (en) | Isoxazol-3(2h)-one analogs as therapeutic agents | |
UA109525C2 (en) | ALKYLAMIDE COMPOUND AND ITS APPLICATIONS | |
MY151726A (en) | Process for production of prasugrel hydrochloride having high purity | |
EA200870586A1 (en) | 3- (1,3-BENZODIOXOL-5-IL) -6- (4-CYCLOPROPYLPIPERAZIN-1-IL) Pyridazine, its salt and its solution and its use as antagonist H3 of the histamine receptor | |
WO2009018065A3 (en) | Novel glucokinase activators and methods of using same | |
MX2010013939A (en) | Substituted n-oxide pyrazine derivatives. | |
TW200624432A (en) | Imidazo [1,2-a] pyridine compounds, compositions, uses and methods related thereto | |
MX352396B (en) | DERIVATIVES OF HETEROARYLSULFONAMIDES, THEIR PREPARATION and THEIR APPLICATION IN HUMAN THERAPY. | |
MX2009011212A (en) | Triazolopyridine carboxamide derivatives and triazolopyrimidine carboxamide derivatives, preparation thereof and therapeutic use thereof. | |
MX2010008361A (en) | Substituted arylamide oxazepinopyrimidone derivatives. | |
MX2007005199A (en) | Substituted indolizines and derivatives as cns agents. | |
WO2008155572A3 (en) | Fused quinoline derivatives useful as gaba modulators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RENW | Renewal (renewal fees accepted) |
Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 22 APR 2016 BY FREEHILLS PATENT ATTORNEYS Effective date: 20130709 |
|
LAPS | Patent lapsed |